Skip to Main Content

News Center

CERSI

M-CERSI Conference Examines Recent Advances in Topical Drug Development

September 10, 2019

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation brings together more than 600 researchers from academia, government, and industry.

M-CERSI Workshop Explores Advances, Challenges in Pediatric Drug Development

September 9, 2019

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.

M-CERSI Conference Spotlights Regulatory Applications for Dissolution Testing

June 13, 2019

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.

Student Competition Spotlights Innovation in Regulatory Science

February 21, 2019

Third-year student pharmacists take the gold for their proposal to establish regulatory standards that protect patient privacy for individuals using wearable and implantable medical technologies.

SOP’s Mattingly Awarded $2.2 Million Grant to Investigate Bulk Drug Substances for Compounding

December 4, 2018

Grant from the U.S. Food and Drug Administration will span three years and include evaluations for more than 200 nominated substances.

M-CERSI Cooperative Agreement Grant Renewed by Food and Drug Administration

October 3, 2018

Latest renewal allows for up to $5 million per year over five years, and will help M-CERSI further advance its mission to promote the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.

Ensuring Prescription Drug Quality for All Patients

May 24, 2018

Dr. James Polli’s extraordinary accomplishments in the field of regulatory science make him a UMB Champion of Excellence.